TANKA Trademark

Trademark Overview


On Monday, July 1, 2024, a trademark application was filed for TANKA with the United States Patent and Trademark Office. The USPTO has given the TANKA trademark a serial number of 98626861. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, January 27, 2025. This trademark is owned by Sanofi. The TANKA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of rare diseases, rare blood disorders, and oncologic, immunologic, and neurologic diseases and disorders; monoclonal and polyclonal antibodies for medical purposes; diagnostic preparations for medical and veterinary use; biological tissue cultures for medical and veterinary use

Scientific research and laboratory research services in the field of biotechnology; biological and pharmaceutical research; biotechnical research; advice being consulting services in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and new component products for third parties, medical and scientific research, namely, conducting clinical trials for others; chemical analysis and research services; medical research; pharmaceutical research services.
tanka

General Information


Serial Number98626861
Word MarkTANKA
Filing DateMonday, July 1, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, January 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of rare diseases, rare blood disorders, and oncologic, immunologic, and neurologic diseases and disorders; monoclonal and polyclonal antibodies for medical purposes; diagnostic preparations for medical and veterinary use; biological tissue cultures for medical and veterinary use
Goods and ServicesScientific research and laboratory research services in the field of biotechnology; biological and pharmaceutical research; biotechnical research; advice being consulting services in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and new component products for third parties, medical and scientific research, namely, conducting clinical trials for others; chemical analysis and research services; medical research; pharmaceutical research services.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressParis 75017
FR

Trademark Events


Event DateEvent Description
Monday, July 1, 2024NEW APPLICATION ENTERED
Tuesday, January 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 27, 2025NON-FINAL ACTION E-MAILED
Monday, January 27, 2025NON-FINAL ACTION WRITTEN
Friday, January 17, 2025ASSIGNED TO EXAMINER